Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03839849
Other study ID # SPU-DN-Perio-1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 9, 2019
Est. completion date December 30, 2019

Study information

Verified date April 2024
Source Syrian Private University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Clinical evaluation of local administration of injectable PRF (injectable platelet-rich fibrin) in periodontal pockets as adjunctive therapy to scaling and root planing. 15 periodontal patients will receive a through traditional mechanical treatment (scaling and root planing). Each patient will receive subgingival i-PRF injected in half mouth and the opposite side will be injected with saline, immediately after the deep scaling session.


Description:

The aim of the study is to evaluate the efficacy of i-PRF subgingival injection right after scaling and root planing as adjunctive therapy to traditional mechanical therapy. 15 periodontal patients will receive traditional mechanical supra and subgingival scaling and root planing. I-PRF will be applied subgingivally in the deep pockets in a half mouth design. The injected half mouth (study group) for each patient will be allocated randomly. The opposite side will be injected with saline (control group). Clinical parameters will be evaluated: plaque index (PI), bleeding on probing (BOP), probing depth (PD), clinical attachment level (CAL). Clinical measurements will be performed at baseline and at 8 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date December 30, 2019
Est. primary completion date September 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Patients are in general good health. - Patients are from both gender and are adult. - A sign informed consent from participation and permission to use obtained data for research purposes. - They have not taken medication known to interfere with periodontal tissue health or healing in the preceding 6 months. - Presence of bilateral periodontal pockets (=5 mm) on the minimum of 2 teeth in each side. Exclusion Criteria: - Patients less than 18 years' old - Immunosuppressive systemic diseases (like cancer, AIDS, diabetes…) - clotting and Hematological disorders - Medications influence on the gingival and periodontal tissues (like calcium channel blockers, or Long-term steroid use - The teeth with poor bad filling and poorly fitted restorations

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
: i-PRF
The description of this intervention has been already given before
saline
The description of this intervention has been already given before

Locations

Country Name City State
Syrian Arab Republic Syrian Private University Damascus

Sponsors (1)

Lead Sponsor Collaborator
Syrian Private University

Country where clinical trial is conducted

Syrian Arab Republic, 

References & Publications (5)

Kour P, Pudakalkatti PS, Vas AM, Das S, Padmanabhan S. Comparative Evaluation of Antimicrobial Efficacy of Platelet-rich Plasma, Platelet-rich Fibrin, and Injectable Platelet-rich Fibrin on the Standard Strains of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. Contemp Clin Dent. 2018 Sep;9(Suppl 2):S325-S330. doi: 10.4103/ccd.ccd_367_18. — View Citation

Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, Choukroun J. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Investig. 2017 Nov;21(8):2619-2627. doi: 10.1007/s00784-017-2063-9. Epub 2017 Feb 2. — View Citation

Varela HA, Souza JCM, Nascimento RM, Araujo RF Jr, Vasconcelos RC, Cavalcante RS, Guedes PM, Araujo AA. Injectable platelet rich fibrin: cell content, morphological, and protein characterization. Clin Oral Investig. 2019 Mar;23(3):1309-1318. doi: 10.1007/s00784-018-2555-2. Epub 2018 Jul 12. — View Citation

Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ. Behavior of Gingival Fibroblasts on Titanium Implant Surfaces in Combination with either Injectable-PRF or PRP. Int J Mol Sci. 2017 Feb 4;18(2):331. doi: 10.3390/ijms18020331. — View Citation

Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets. 2018 Jan;29(1):48-55. doi: 10.1080/09537104.2017.1293807. Epub 2017 Mar 29. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical attachment level (CAL) measure as the change in distance from the cementoenamel junction to the bottom of the gingival sulcus by using a periodontal probe (UNC 15 "University of North Carolina") baseline, 2 months
Primary Probing pocket depth (PD) measure as the change in distance from the gingival margin GM to the bottom of the gingival sulcus by using a periodontal probe (UNC 15 "University of North Carolina") baseline, 2 months
Secondary full mouth Plaque Index Quigely Hein Index (modified by Turesky et al, 1970) 0 No plaque
Separate flecks of plaque at the cervical margin of the tooth
A thin continuos band of plaque (up to one mm) at the cervical margin of the tooth
A band of plaque wider than one mm but covering less than one-third of the crown of the tooth
Plaque covering at least one-third but less than two-thirds of the crown of the tooth
Plaque covering two-thirds or more of the crown of the tooth labial/ buccal and lingual surfaces are assessed after using disclosing solution.
An index for the entire mouth is determined by dividing the total score by the number surfaces examined.
baseline, 2 months
Secondary Modified Gingival Index (Trombelli et al. 2004) 0 = Normal gingiva;
= Mild inflammation - slight change in color and slight edema;
= Moderate inflammation - redness, edema and glazing;
= Severe inflammation - marked redness and edema, ulceration with tendency to spontaneous bleeding.
will be evaluated visually
baseline, 2 months
Secondary Bleeding on probing (BOP) All six sites of all teeth are assessed with regard to whether probing elicits bleeding (+) or not (-). The severity of gingivitis is expressed as a percentage.
- no bleeding upon probing (not recorded)
+ bleeding upon probing
Calculation:
BOP= Number of bleeding sites x100/ Number of sites evaluated will be evaluated visually and used a UNC-15 mm "University of North Carolina" periodontal probe
baseline, 2 months